## IFF: International Flavors & Fragrances Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 2.4% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($63.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Corient Private Wealth LLC Has $7.88 Million Stock Holdings in International Flavors & Fragrances Inc. $IFF**
- Source: MarketBeat | 20251220T085655 | Neutral | Relevance: 100%
- Corient Private Wealth LLC reduced its stake in International Flavors & Fragrances Inc. (IFF) by 38.9% in the second quarter, now holding 107,107 shares valued at $7.88 million. Despite this, institutional ownership of IFF remains high at 96.02%, with other firms like Dodge & Cox increasing their holdings significantly. Analysts maintain a "Moderate Buy" consensus rating for IFF with a target price of $85.02, following the company's slight beat on quarterly EPS and revenue estimates, alongside a declared quarterly dividend of $0.40 per share.

**2. Bio-Tech Flavor Market Generated Opportunities, Future Scope**
- Source: openPR.com | 20251222T100927 | Somewhat-Bullish | Relevance: 95%
- The Bio-Tech Flavor Market is experiencing rapid innovation, rising investment, and shifting regional dynamics, necessitating strategic insights for decision-makers. A new report provides a comprehensive analysis of the market from 2025 to 2032, detailing segmentation by Type, Application, and Region, along with financial breakdowns of major companies like Givaudan S.A. and International Flavors & Fragrances Inc. The study aims to help businesses identify growth opportunities, target partners, and refine their strategies within this evolving landscape.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($2.72M) |
| Sells | 1 ($0.75M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Dodge & Cox Inc.: 14.4% (+5.5%)
- Vanguard Group Inc: 12.2% (+0.8%)
- Freemont Capital Pte: 9.9% (0.0%)
- Blackrock Inc.: 7.2% (-16.4%)
- State Street Corpora: 4.3% (+0.8%)

### Key Risks

1. Long-term trend broken: trading 5.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 14.9x stretched relative to 5% growth. Insider buying signal ($2.7M), management confidence. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.1B |
| Beta | 1.04 |
| 52W Range | $59.14 - $88.09 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 14.9 |
| Current P/E | 15.6 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.5% to 2.4% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 54. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.35% (CS: 86) | Neutral |
| RSI_14 | 54.5 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.023x | Above |
| vs SMA200 | 0.945x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $66.55
- **Stop Loss:** $63.25 (5.0% risk)
- **Target:** $69.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 272
- **Position Value:** $18,101.60
- **Portfolio %:** 18.10%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-17 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.02 | $1.05 | +3.3% |
| 2025Q2 | $1.12 | $1.15 | +2.5% |
| 2025Q1 | $1.14 | $1.20 | +5.7% |
| 2024Q4 | $0.82 | $0.97 | +17.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*